Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery Platform
Sponsor : Fujitsu
Deal Size : Undisclosed
Deal Type : Merger
Japan's Fujitsu, Mizuho, PeptiDream to Establish Joint Venture to Develop COVID-19 Treatments
Details : The new company, to be called PeptiAID Inc, will research and develop peptide therapeutics for the current SARS-CoV-2 virus and potential future coronavirus outbreaks.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
December 11, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery Platform
Sponsor : Fujitsu
Deal Size : Undisclosed
Deal Type : Merger